Comparative pharmacovigilance assessment of adverse events associated with the use of hydroxyurea, L‐glutamine, voxelotor, and crizanlizumab in sickle cell disease.
- Resource Type
- Article
- Source
- American Journal of Hematology; Feb2024, Vol. 99 Issue 2, pE37-E41, 5p
- Subject
- Language
- ISSN
- 03618609